Tower Research Capital (TRC)’s Context Therapeutics CNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.86K | Sell |
7,414
-5,890
| -44% | -$3.86K | ﹤0.01% | 4254 |
|
|
2025
Q1 | $8.14K | Buy |
13,304
+12,370
| +1,324% | +$7.57K | ﹤0.01% | 3915 |
|
|
2024
Q4 | $981 | Sell |
934
-6,221
| -87% | -$6.53K | ﹤0.01% | 5122 |
|
|
2024
Q3 | $14K | Buy |
+7,155
| New | +$14K | ﹤0.01% | 3482 |
|
|
2024
Q2 | – | Sell |
-6,357
| Closed | -$8.77K | – | 5720 |
|
|
2024
Q1 | $8.77K | Sell |
6,357
-298
| -4% | -$411 | ﹤0.01% | 3966 |
|
|
2023
Q4 | $7.52K | Sell |
6,655
-2,308
| -26% | -$2.61K | ﹤0.01% | 4608 |
|
|
2023
Q3 | $13.5K | Buy |
8,963
+3,026
| +51% | +$4.57K | ﹤0.01% | 3778 |
|
|
2023
Q2 | $9.5K | Sell |
5,937
-2,906
| -33% | -$4.65K | ﹤0.01% | 4247 |
|
|
2023
Q1 | $5K | Sell |
8,843
-14
| -0.2% | -$8 | ﹤0.01% | 4943 |
|
|
2022
Q4 | $6K | Buy |
8,857
+1,558
| +21% | +$1.06K | ﹤0.01% | 4696 |
|
|
2022
Q3 | $8K | Buy |
7,299
+4,331
| +146% | +$4.75K | ﹤0.01% | 4767 |
|
|
2022
Q2 | $6K | Buy |
2,968
+2,935
| +8,894% | +$5.93K | ﹤0.01% | 4902 |
|
|
2022
Q1 | $0 | Sell |
33
-2,021
| -98% | – | ﹤0.01% | 6134 |
|
|
2021
Q4 | $6K | Buy |
+2,054
| New | +$6K | ﹤0.01% | 5013 |
|